79201268

Information

  • Trademark
  • 79201268
  • Serial Number
    79201268
  • Registration Number
    5499785
  • Filing Date
    October 10, 2016
    9 years ago
  • Registration Date
    June 26, 2018
    7 years ago
  • Transaction Date
    February 04, 2025
    a year ago
  • Status Date
    January 10, 2025
    a year ago
  • Published for Opposition Date
    April 10, 2018
    7 years ago
  • Location Date
    June 26, 2018
    7 years ago
  • Status Code
    709
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    VAGHANI, MAYUR
  • Attorney Name
    Beth E. Cooperstein
    Law Office Assigned Location Code
    N60
  • Owners
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of a stylized sketch design of a walking man with a shadow to the right.
  • GS0051: Chemical products intended to be integrated in medicines so as to improve their effectiveness, namely, pharmaceutical excipients sold as an integral component of medicines so as to promote dissemination in a given area of the human body; pharmaceutical excipients, namely, drug delivery agents consisting of chemical compounds that improve delivery of a wide range of pharmaceuticals; pharmaceutical substances for medical use, namely for treatment of diabetes; pharmaceutical and veterinary products, namely for treatment of diabetes
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemical products for use in science, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes; chemical products for use in the medical and pharmaceutical industries, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptides substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes
  • GS0421: Medical research; scientific and technological services, namely, scientific analysis, scientific research and development and design and testing of new products for others, clinical research, all in the field of treatment of diabetes
Case File Event Statements
  • 2/14/2017 - 9 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/9/2017 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/10/2017 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/10/2017 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/15/2017 - 9 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/16/2017 - 9 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/17/2017 - 9 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/17/2017 - 9 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/11/2017 - 8 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/7/2017 - 8 years ago
    10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 8/15/2017 - 8 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/15/2017 - 8 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/16/2017 - 8 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/6/2017 - 8 years ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 9/6/2017 - 8 years ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 9/6/2017 - 8 years ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 3/6/2018 - 7 years ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 3/7/2018 - 7 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/21/2018 - 7 years ago
    21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/21/2018 - 7 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/21/2018 - 7 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/6/2018 - 7 years ago
    24 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 4/10/2018 - 7 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/10/2018 - 7 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/26/2018 - 7 years ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/26/2018 - 7 years ago
    28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/28/2018 - 7 years ago
    29 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/28/2018 - 7 years ago
    30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/26/2023 - 2 years ago
    32 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 1/10/2025 - a year ago
    33 - CANCELLED SECTION 71 Type: C71T
  • 10/19/2018 - 7 years ago
    31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/6/2018 - 7 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/6/2018 - 7 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA